tesaglitazar protective_against insulin resistance
Evidence from:
primary |
all sources
Evidence (2 sources)
The PPAR α / γ Agonist, Tesaglitazar, Improves Insulin Mediated Switching of Tissue Glucose and Free Fatty Acid Utilization In Vivo in the Obese Zucker Rat.
(2013)
PMID:24285952
cited
tesaglitazar induced amelioration of insulin resistance in key insulin target tissues
confidence: 0.95
The PPAR α / γ Agonist, Tesaglitazar, Improves Insulin Mediated Switching of Tissue Glucose and Free Fatty Acid Utilization In Vivo in the Obese Zucker Rat.
(2013)
PMID:24285952
cited
tesaglitazar ameliorates insulin resistance in patients with type 2 diabetes
confidence: 0.95